Internal Medicine, Gastroenterology · Toms River, NJ
NPI
1932148327
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
477 Lakehurst Rd
Toms River, NJ, 08755
Phone (732) 349-4422
Groups this clinician bills Medicare through
Medicare paid, 2024
$200K
1,960 services
Medicare patients, 2024
1,011
Average age 75
Drug cost, 2024
$1.5M
4,683 prescriptions
Company payments, 2025
$67.9
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Omar A Tamimi was code 99214 (office e&m - established), 620 times for 462 patients. In total Omar A Tamimi billed 1,960 services in 50 codes, and Medicare paid $200K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 620 | 462 | $99.87 | $62K |
| 99232 Hospital E&M - Subsequent | Facility | 225 | 141 | $63.20 | $14K |
| 99213 Office E&M - Established | Office | 163 | 153 | $70.17 | $11K |
| 43239 Upper GI Endoscopy | Facility | 155 | 152 | $84.76 | $13K |
| 99204 Office E&M - New | Office | 136 | 136 | $117.43 | $16K |
| 45385 Colonoscopy - Lesion Removal | Facility | 134 | 134 | $212.29 | $28K |
| 99203 Office E&M - New | Office | 89 | 89 | $77.95 | $6,938 |
| 99222 Hospital E&M - Initial | Facility | 65 | 65 | $102.26 | $6,647 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 57 | 57 | $187.01 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 49 | 48 | $13.69 | $671 |
| 76981 Ultrasound - Nonspecific | Office | 49 | 49 | $86.38 | $4,233 |
| 45380 Lower GI Endoscopy - Other | Facility | 35 | 35 | $120.12 | $4,204 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 32 | 30 | $183.23 | $5,863 |
| 91065 Test - Miscellaneous | Office | 24 | 16 | $61.17 | $1,468 |
| 45378 Lower GI Endoscopy - Other | Facility | 22 | 22 | $150.72 | $3,316 |
By year: 2022 $216K for 2,436 services; 2023 $195K for 1,923 services; 2024 $200K for 1,960 services.
Medicare prescription drug claims, 2024
In 2024, the drug Omar A Tamimi prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,021 prescriptions and refills. In total Omar A Tamimi wrote 4,683 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,021 | 2,638 | 344 | $15K |
| Famotidine Generic | 873 | 2,320 | 299 | $16K |
| Esomeprazole Magnesium Generic | 309 | 845 | 104 | $12K |
| Omeprazole Generic | 264 | 761 | 91 | $4,720 |
| Dicyclomine Hcl Generic | 252 | 455 | 126 | $6,240 |
| Dexlansoprazole Dr Dexlansoprazole | 198 | 424 | 66 | $72K |
| Sucralfate Generic | 138 | 249 | 64 | $13K |
| Hydrocortisone Generic | 120 | 122 | 55 | $2,428 |
| Creon Lipase/Protease/Amylase | 114 | 198 | 27 | $488K |
| Ondansetron Odt Ondansetron | 102 | 124 | 61 | $2,925 |
| Linzess Linaclotide | 76 | 154 | 27 | $80K |
| Mesalamine Generic | 74 | 162 | 25 | $57K |
| Loperamide Loperamide Hcl | 70 | 90 | 36 | $1,953 |
| Lubiprostone Generic | 60 | 90 | 21 | $5,690 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 60 | 67 | 19 | $2,262 |
Brand drugs: - claims; generic drugs: 4,118 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Omar A Tamimi $67.9 ($67.9 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $49.68.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.